Inhaler
Latest AstraZeneca AB Patents:
- Amido heteroaromatic compounds
- Methods of delaying pain progression and treating prostate cancer
- Methods of treating chronic kidney disease with dapagliflozin
- PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4- OXAZEPANE-2-CARBOXAMIDE
- Compositions and methods of treating cancer with chimeric antigen receptors
Description
FIG. 1 is a perspective view of an inhaler with a mouthpiece in accordance with the invention.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D448076
Type: Grant
Filed: May 15, 1998
Date of Patent: Sep 18, 2001
Assignee: AstraZeneca AB (Södertälje)
Inventor: Alfred von Schuckmann (Kevelaer)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Martin A. Farber
Application Number: 29/112,848
Type: Grant
Filed: May 15, 1998
Date of Patent: Sep 18, 2001
Assignee: AstraZeneca AB (Södertälje)
Inventor: Alfred von Schuckmann (Kevelaer)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Martin A. Farber
Application Number: 29/112,848
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;
